Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 59.50
+0.70 (1.19%)
At close: Nov 4, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 6.39 billion as of November 4, 2026. It is the 29,815th most valuable company in the world and the 91st biggest in Bangladesh. Its market cap has increased by 13.77% in one year.
Market Cap
6.39B
Enterprise Value
10.04B
Revenue
10.57B
Global Rank
Country Rank
#91 Bangladesh
PE Ratio
10.62
ChartMarket Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 6.39B, an increase of 125.38%. That is a compound annual growth rate of 22.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 6.39B | 14.64% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 21.00B |
| The ACME Laboratories | 16.42B |
| Asiatic Laboratories | 13.06B |
| The IBN SINA Pharmaceutical Industry | 9.29B |
| Orion Pharma | 6.39B |
| Techno Drugs | 4.47B |
| Ambee Pharmaceuticals | 1.75B |
| Pharma Aids | 1.68B |